FDA Approves New Indication for Gilotrif

Afatinib (Boehringer Ingelheim) gets a new indication for the first-line treatment of patients with metastatic ...

JANUARY 18, 2018

Pipeline Looks Strong for 2018 New Oncology Drugs

This year looks like a strong one for cancer medication approvals, highlighted by expected approvals of more oral ...

JANUARY 16, 2018

Higher Opioid Use Seen Among Cancer Survivors

A recent analysis found that cancer patients receive more opioid prescriptions, even years after their cancer is ...

AUGUST 8, 2017

Challenges to Cancer Pain Management Are Multifactorial

In the 1980s, up to 70% of cancer patients reported pain. Thirty years later, cancer pain prevalence has not ...

JUNE 26, 2017

The Top Killer In Breast Cancer May Surprise You

Women in their 40s and 50s are experiencing heart failure and other cardiotoxicities after treatment with ...

JUNE 14, 2017

Contaminated IVs Infect Cancer Patients

A compounded IV flushing solution was the culprit.

NOVEMBER 18, 2016

The Politics of Health Care Reform

Two policy experts, one Republican and one Democrat, square off about the possible effects the election outcome ...

OCTOBER 11, 2016

An Aspirin a Day May Keep Cancer, Heart Disease at Bay

The U.S. Preventive Services Task Force has recommended the use of aspirin for primary prevention of cardiovascular ...

AUGUST 30, 2016

Quinolones Reduce Infections, Delay Febrile Neutropenia in Relapsed/Refractory AML Patients

Treating patients with relapsed/refractory AML prophylactically with quinolones reduced the incidence of bacteremia ...

JULY 5, 2016

VP Biden: Let’s ‘End Cancer as We Know It'

Vice President Joe Biden told more than 4,000 attendees at the 2016 annual meeting of the American Association for ...

APRIL 21, 2016